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SUMMARY 
A method to introduce multiple mutations and to reconstruct genes, using a single oligodeoxyribonucleotide 
and DNA polymerase with high processivity, such as modified T7 DNA polymerase [Tabor and Richardson, 
Proc. Natl. Acad. Sci. USA 84 (1987a) 4767-47711, is described. A eukaryotic cDNA, coding for porcine 
growth hormone (pGH), was reconstructed in this study to delete 75 bp and to introduce a G + A transition. 
The deletion removes 75 bp and brings an ATG just upstream from the codon for the first amino acid in the 
mature protein. Moreover, the G 4 A substitution creates a new PvuII restriction site to facilitate further 
manipulation of the gene. Maximum mutation frequency with this multisite-directed mutagenesis is reached 
within 15 min with an efficiency approaching 50%, when using the modified T7 DNA polymerase. No 
multisite-directed mutants were obtained when T4 DNA polymerase or Klenow (large) fragment of DNA 
polymerase I were used. The described method is also applicable to simple single site-directed mutations as 
well as to more complex gene reconstruction strategies. 
INTRODUCTION 
In vitro mutagenesis, random or site-specific, pro- 
vides a powerful tool to study the biological activity 
of genes and their proteins (Smith, 1985). Another 
major potential application for site-directed muta- 
genesis is in gene reconstructions for the purpose of 
heterologous gene expression of eukaryotic genes in 
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prokaryotic cells. The application of site-directed 
mutagenesis to eukaryotic gene reconstruction for 
expression in bacteria has been very limited. Sollazzo 
et al. (1985) have constructed deletion mutants in 
ss vectors in Escherichiu coli. Site-specific methods 
that employ phenotypic selection have improved the 
efficiency of in vitro mutagenesis (Kunkel, 1985; 
Kunkel et al., 1987). In this paper we report an 
improved and efficient way to do major gene recon- 
structions in a single step by site-directed muta- 
genesis using pGH cDNA as an example, and by 
employing modified T7 DNA polymerase (Tabor 
and Richardson, 1987a,b). Modified T7 DNA poly- 
merase is stable, procesessive, has a high rate of 
DNA polymerization (> 300 nt/s), and is essentially 
99% free of its 3’-to-5’ exonuclease activity (Tabor 
and Richardson, 1987a,b; Tabor et al., 1987; Huber 
et al., 1987). These features suggested the use of 
modified T7 DNA polymerase for site-directed 
mutagenesis. 
MATERIALS AND METHODS 
(a) Plasmid constructions 
The pMC1403 plasmid containing the full-length 
pGH cDNA was generously supplied by S.Z. Qi 
(Beijing Agricultural University). This clone was 
selected from pig pituitary gland cDNA library using 
two synthetic oligo probes (Xia, 1987). A BumHI- 
EcoRI fragment containing the pGH coding se- 
quence was removed from pMC1403 and subcloned 
in M13mp18 (Messing, 1983) in the corresponding 
sites. Plasmid pMC1403 and dsDNA of M13mp18 
RF were mixed at a ratio of 4 : 1 and cleaved simulta- 
neously with BumHI + EcoRI. Completeness of the 
digestion was determined by 0.8% agarose gel elec- 
trophoresis. The DNA was extracted with phe- 
nol/chloroform and precipitated with 2.5 ~01s. of 
cold ethanol. After washing with 70 y0 ethanol, DNA 
was dried and resuspended in 1 x ligation buffer 
(10 mM Tris . HCI pH 7.4, 10 mM MgCI,, 50 mM 
NaCI, 0.5 mM DTT). T4 DNA ligase (0.5 unit) and 
ATP (to 1 mM) were added to ligate the resulting 
restriction fragments. The reaction mixture was then 
used to transfect JMlOl (Yanisch-Perron et al., 
1985). White plaques were selected and ssDNA was 
isolated and sequenced to verify the 5’ terminus. 
(b) DNA preparations 
All plasmid DNA preparations were made using 
the mini alkaline lysis method (Birnboim and Daly, 
1979). Ml3 dsDNA or ssDNA was prepared using 
Messing’s (1983) method. 
(c) Site directed mutagenesis 
(I) The ohgodeoxynucleotide 
An oligo of 34 nt complementary to pGH coding 
gene in the ‘plus’ ( + ) strand of Ml3 was prepared 
by the phosphoramidite method using an Applied 
Biosystems 380A DNA synthesizer and then puri- 
fied by HPLC. The oligo sequence is as follows: 
5’-CAGCTCACCAGCTGTGATGTTCCCAGC- 
CATGCCC-3 ’ . 
This oligo is homologous to two different regions 
in the pGH gene and also contains a single nt sub- 
stitution of G + A at the nt position -7. The oligo 
was phosphorylated by T4 polynucleotide kinase 
(Maniatis et al., 1978) using a trace quantity of 
[ y-32P]ATP in addition to the cold ATP to monitor 
the kinase reaction. Following the reaction the un- 
incorporated ATP was removed by precipitation of 
the oligo with 3 ~01s. of cold lOOo/, ethanol, and 
washed twice with cold 70% ethanol. The oligo was 
dried and then resuspended in sterile double-distilled 
water. 
(2) The procedures 
The recombinant bacteriophage M 13mp 18 
containing pGH-coding cDNA (M13.pGH) was 
used to infect Escherichia coli strain RZ 1032 (ung 
dut-) (Kunkel et al., 1987). This step produces a 
DNA template containing a small number of uracil 
residues in place of thymine (Kunkel, 1985). After 
three propagative cycles of infection in the RZ1032 
strain, M13.pGH ssDNA was prepared. Samples 
containing this DNA (500 ng/reaction) were used to 
test three different reactions to make the site-directed 
changes. Two reactions (A and B) served as con- 
trols. In all these protocols, the mutagenic oligo was 
first annealed to the DNA. 
(A) One aliquot was treated according to 
Kunkel’s (1985) procedure using T4 DNA poly- 
merase and T4 DNA ligase for 30 min at 37°C. 
(B) A second sample was incubated with Pollk at 
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0°C overnight followed by T4 DNA ligase. In 
another experiment requiring the introduction of a 
limited number of nt substitutions these modifi- 
cations had increased the fraction of mutants 
recovered (El-Gewely et al., 1988). 
(C) A modified T7 DNA polymerase (Tabor and 
Richardson, 1987) known commercially as Se- 
quenaseTM (United States Biochemicals Corpora- 
tion, P.O. Box 22400, Cleveland, OH 44122) was 
added to the final sample. The steps and buffers 
employing this enzyme are described below. 
(3) Buffers and solutions 
(i) 5 x T7 polymerase buffer: 200 mM Tris . HCl, 
pH 7.5, 100 mM MgCI,, and 250 mM NaCl. 
(ii) Deoxyribonucleotide mix (dNTP) for site- 
directed mutagenesis: 500 PM dATP, 500 PM 
dGTP, 500 PM dCTP, 500 PM dTTP, and 50 PM 
Tran+dua* rtraim 
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Fig. 1. The strategy for the multisite-directed mutagenesis of pGH-coding cDNA by T7 polymerase method. The BumHI-EcoRI 
fragment containing pGH cDNA was inserted in M13mpl8 and this recombinant bacteriophage was designated Ml3.pGH. A 
U-containing M 13.pGH DNA template was prepared after growing in RZ1032 strain (ung- dut ) for two or three cycles. The resulting 
template was used to anneal the mutagenic synthetic 34-mer (looping out 75 bp, see Fig. 2) and the complementary strand was made 
by modified T7 DNA polymerase and T4 DNA ligase, followed by transfecting strains JM 101 (ung’ dut + ) and RZ 1032 (as control). 
The survivors on JMlOl were screened for putative mutants by the appearance of a new PvuII restriction site and sequencing analysis. 
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DTT. This mix was made in 1 x T7 polymerase 
buffer. 
(iii) ATP solution: 10 mM ATP, in sterile double- 
distilled water. 
(iv) Primer/oligo solution: the phosphorylated 
primer/oligo was diluted with sterile double-distilled 
water to a final concentration of 0.5 pmol/jL 
In a small eppendorf tube the following were 
mixed: 3 1.11 of DNA template (approx. 500 ng, 
0.19 PM), 4 ~1 H,O, 1 ~1 primer (0.5 PM), 2 ~1 
5 x T7 polymerase buffer. 
This mix was heated at 65°C for 5 min, then the 
temperature was allowed to cool slowly to room 
temperature over a period of 60 min. After incuba- 
tion at room temperature for 15 min, the sample was 
incubated on ice for an additional 15 min. 
(5) Extemion urzd ligation reaction 
The following were added to the above mix (on 
ice): 2 ~1 of dNTP mix, 1.5 ~1 of ATP solution, 1 ~1 
(14 units/PI) of modified T7 polymerase (Se- 
quenaseTM), and 2 units of T4 DNA ligase. 
The reaction was allowed to proceed at 37°C for 
5, 10, 15, 30, and 60 min to test the effect of time on 
mutation frequency. The reaction was stopped by 
heating at 65 O C for 5 min. The effect of adding more 
tigase (5 units) in the reaction mix was also tested. 
Aliquots from each experiment were used to trans- 
feet RZ 1032 or JMlOl competent cells. 
(d) Restriction enzyme analysis for the screening of 
putative mutants 
Twelve different plaques from each reaction/ 
experiment that survived on JM 10 1, were picked and 
their DNA was isolated using the alkaline lysis 
method (~i~boim and Doly, 1979). The isolated ds 
DNA was then analyzed by PvuII restriction enzyme 
digestion. The digested DNA was subjected to poly- 
acrylamide gel electrophoresis (3.50/,) and the DNA 
band were visualized by staining with ethidium 
bromide. 
(e) Nucleotide sequencing 
The dideoxy method (Sanger et al., 1977) was 
used to verify the sequence of the mutations after 
initial screening by restriction analysis with PvuII. 
TTTTTTTTT? ’ ~GTGGGGAA GAGGACTTTT ATTGGGATGT TAGTGGGGGA 
-53 
CTCCAGGGAA CAACAAACAC TAGGACCCAG CTCCCCAGAC CACTCAGGGA 
-16 
CCTGTGGACA GCTCACC&C TGTGifG&:T GCAGGCCCTC GGACCTCCGT 
CA GCT CA ccA*Gc TGTGATG 
Pvull 
+74 
GCTCCTGGCT TTCGCCCTGC TCTGCCTGCC CTGGACTCAG GAGGTGGGCG 
75 base long deletion 
&CCCAGC CATGCC%G TCCAGCCTAT TTGCCAACGC CGTGCTCCGG 
-TTCCCAGC CA TGCCC 
34-mer Prfmef 
Fig. 2. Sequence of the S’-terminus of pGH-coding cDNA, indicating the 34-mer mutagenic primer. The numbering is relative to the 
ATG start codon (A = + 1). The primer overiaps the cDNA sequence from -17 to + 4 and from + 79 to t 93, with the G ---* A 
substitution at -7. The 75-nt long deletion region is underlined. The ATG start codon of pre-pGH cDNA is positioned at the first codon 
of mature pGH (TCC) as a result of the deletion. A PvuII restriction site (5’-CAGCTG) is generated by the G + A substitution as shown 
by an asterisk and large letter A. 
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Modified 1-7 DNA polymerase (SequenaseTM) was 
used according to the manufacturer’s instructions. 
[35S]dCTP (Amersh~) was used (Biggins et al., 
1983) and gel electrophoresis was performed as 
described by Sanger and Coulson (1978). 
RESULTS AND DISCUSSION 
(a) Strategy 
The strategy to make the multiple changes in pGH 
gene is illustrated in Fig. 1. pGH cDNA was sub- 
cloned in Mi3mp18 to give the recombinant phage 
M13.pGH. Before any gene reconstruction, the 
5’ terminus of the cloned pGH coding gene was 
verified by sequencing. The nucleotide sequence at 
this end was in agreement with published work 
(Seeburg et al., 1983; Vize et al., 1987) except for a 
silent substitution where A (nt 25 in the presequence) 
was replaced by C without changing the aa (Gly). 
The 5’-untranslated sequence usptream from posi- 
tion -54 was found to be different from the published 
sequence (Vize et al., 1987). The complete sequence 
of the 5’ terminus of the pGH coding gene indicating 
these changes is shown in Fig. 2. DNA templates 
containing uridinyl residues were prepared by infect- 
ing RZ 1032 strain with M 13.pGH. As expected after 
two or three propagative cycles of infection in 
RZ1032 (Kunkel, 1985), the survival of this U-con- 
taining DNA in the wild-type strain (JMlO~) is 
greatiy reduced. The U-containing DNA template 
was annealed with the synthetic primer (Figs. 1 
and 2) causing the looping out of 75 nt, bringing the 
ATG immediately 5’ to the first codon of the mature 
TABLE I 
Effect of oligodeoxynucleotide extension and ligation time on the survival of M 13.pGH in strain JM 101 and on mutation frequency iI 
Timeh -- 
__ 











0.32 9.4 3.4 31 
0.68 8.8 1.1 45 
6.4 12 53 42 
2.6 13 20 38 
0.34 11 3.1 8 
0.01 9.1 0.13 0 
._ 
‘I Uracil-containing DNA template was prepared using RZl032 strain (ung- dur - ) as described by Kunkel (1985). Cells were grown 
in YT medium (yeast extract, 5 mg/ml; tryptone, 8 mg/ml; NaCl, 5 mg/ml) supplemented with thymidine (20 pg/ml) and deoxyadenosine 
(100 pg/ml) until absorbance of 0.6 is reached (A,,,). Cells were centrifuged for 15 min at 2000 x g, washed with YT medium, 
resuspended in the same volume of YT medium containing uridine (0.25 &ml), and then infected with the recombinant bacteriophage 
M13mp18 containing pGH cDNA (M13.pGH) at a multiplicity of infection of 1 to 10. Incubation at 37°C was continued overnight (first 
cycle of growth). Cultures were centrifuged and the M 13.pGH bacteriophage in the supernatant fraction was titrated and then 2nd and 
3rd cycles of RZ1032 infection were repeated in uridinc containing YT medium. Uracil-cont~ning DNA was titrated on both JMlOl 
(ung’ &+) and RZ1032. 
’ Time after adding modified T7 DNA polymerase and T4 ligase to the reaction mix. Samples were incubated at 37°C (see MATERIALS 
AND METHODS, section c). 
V pfu/ng of U-containing DNA on JMIOl, and RZ1032. IO-$ portions, out of the reaction mix (30~1) were used to transfect JMlOl 
strain while S-p1 portions were used to transfect RZ.1032. 
t( Survival of U-containing DNA of M13.pGH on both strains JMlOl and RZ1032. Survival % was calculated as (number of plaques 
on JMlOl divided by number of plaques on RZ1032) x 100. 
D Mutation ?,; is calculated as total number of mutants x 100 divided by total number ofplaques (on JMlOl). Mutants were identified 
by the appearance of a new PvuIl restriction site when analyzed by 3.5% polyacrylamide gel electrophoresis (see Fig. 4. legend, map A 
and panel B). 
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protein. The same primer included a G --f A substi- 
tution generating a PvuII restriction site. 
(b) The use of T4 DNA polymerase (method A) and 
PolIk (method B) in multisite directed mutagenesis 
Plaques obtained on JM 101 using T4 polymerase 
or PolIk as described showed no mutagenic changes 
as judged by PvuII restriction enzyme analysis. 
It can be concluded from these experiments that 
the use of T4 polymerase (Kunkel, 1985) or PolIk at 
0°C did not result in efficient multisite-directed 
mutagenesis of the type described here. Simpler site- 
directed changes (two nt substitutions) were made 
previously using PoIIk under these conditions which 
minimize the 3’-to-5’ exonuclease activity (El- 
Gewely et al., 1988). 
% I 
-.- *“r”,“oi ‘1. 
-20 
0 10 20 30 40 50 60 
Time Cmln) 
Fig. 3. The relationship between reaction time and mutation 
frequency. 500 ng of M I3.pGH U-containing template was mixed 
with synthetic 34-mer at a molar ratio of 1: 2-3 in 1 x T7 DNA 
polymerase buffer. The mixture was heated at 65’C for 5 min, 
then allowed to cool slowly to room temperature and then placed 
on ice. 1.5 ~1 IO mM ATP, 1 ~1 of modified T7 DNA polymerase 
(14 units), and 1~1 of T4 ligase (5 units) were added. The 
reaction was incubated at 37°C for various times, and stopped 
by heating at 65°C for 5 min. Transfections were done in JM 101 
and RZi032 to determine the survival percentage ([number of 
plaques on JMlOl/number of plaques on RZ1032] x 100) and 
transfection effciency ([number of plaques on RZ1032i~g 
DNA] x 100). Samples of DNA from twelve different plaques 
that survived on JMIOI were isolated and analyzed (see 
MATERIALS AND METHODS, section d) using 3.5’); poly- 
acrylamide gel electrophoresis. The mutation frequency was 
based on the PvuII analysis where the mutant constructions are 
cleaved by an additional PvuII site (see RESULTS AND 
DISCUSSION, section e, and Fig. 4, panel B). 
(c) The use of modified T7 polymerase in multisite- 
directed mutagenesis 
The use of modified T7 DNA polymerase in the 
oligo extension reaction have resulted in the multiple 
changes required for reconstruction as outlined in 
Figs. 1 and 2. In Table I, it is indicated that even 
after a 5-min reaction, 3 1 “/, of surviving plaques on 
J M 10 1 contained the change. The frequency of muta- 
tion increased with reaction time and then slowly 
decreased (Table I and Fig. 3). At these conditions, 
the optimum time for survival of the resulting DNA 
by forming plaques on JMlOl was around 15 min. 
The mutation frequency was also the highest after 
10-l 5 min of incubation. Unlike survival percentage, 
incubation time between 5-60 min did not drasti- 
cally affect mutation rate. Transfection efficiency 
(pfu/ng) was not affected by the time of incubation 
after an initial increase in the first 10 min (Table I 
and Fig. 3). 
(d) The effect of the concentration of T4 ligase on 
mutation frequency 
The mutation and the survival percentages were 
improved by the use of higher concentrations of T4 
DNA ligase (5 units per reaction instead of 2 units 
per reaction, Table II). 
The higher concentration of ligase was added in 
the reaction to ensure ligation of the new strands as 
soon as they are formed thus reducing any possible 
second cycle read-through by T7 polymerase. Long 
incubation with the enzyme (60 min) reduced the 
survival percentage as well as the mutation frequency 
when the resulting DNA was transfected into 
JM 101. It is possible that longer incubation time 
results in the displacement of the mutagenic oligo 
and the newly synthesized strand producing multiple 
rounds of DNA replication. Aberrant products may 
be subject to DNA repair mechanisms reducing both 
the survival percentage and the frequency of mutants. 
Since longer incubation time did not affect trans- 
fection efficiency, we can rule out the presence of 
residual molecules with 3’ -to-5 ’ exonuclease activity 
as an explanation for the reduction of both the 
survival of M13.pGI-I on JMlOl and the mutatio~l 
frequency. Modified T7 DNA polymerase prepara- 
tion contains some molecules (0.01%) that still 
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a T4 ligase (O-5 units) per reaction were added simultaneously with modified T7 DNA polymerase (14 units) (see MATERIALS AND 
METHODS, section c). 
b See corresponding footnotes c-e to Table I. 
(e) Restriction enzyme analysis for the screening of 
putative mutants 
The results of PvuII restriction enzyme digestion 
of DNA from putative mutants are shown in Fig. 4. 
Mutant DNA could be identified by the absence of 
the 890-bp fragment and the appearance of the two 
DNA fragments of 568 and 247 bp. Together the two 
fragments add up to a total of 8 15 bp reflecting both 
the introduction of a new PvuII site in the 890-bp 
fragment and the deletion of 75bp presequence 
(Fig. 4). 
(f) Nucleotide sequence analysis of the reconstructed 
pGH gene 
Sequence of the mutants, as judged by the restric- 
tion analysis, was confirmed by nucleotide se- 
quencing (Fig. 4). All of the tested mutants had the 
predicted sequence including the G + A substitution 
creating a PvuII site (CAGCTG), and the 75bp 
deletion from nt + 4 (G) to nt + 78 (C) (Figs. 2 
and 4). This deletion introduced ATG just upstream 
from TTC coding for the initial N-terminal amino 
acid, phenylalanine, in the mature protein. 
It appears that the described method of site- 
directed mutagenesis using modified T7 DNA poly- 
merase has succeeded in introducing multiple, simul- 
taneous changes using a single oligo. 
This method has been useful in making simpler 
site-directed changes as well (M. Adams, personal 
communication). Also, this method and procedure 
was used to introduce an insertion of 29 bp in pGH 
coding sequence that included EcoRI restriction en- 
zyme site, ribosome-binding site, and additional 
codons for methionine, alanine, and glutamic using 
a single 59-nt oligo (unpublished). This method 
should also be applicable in cases where more than 
one mutagenic primer are used to introduce simul- 
taneous changes in different domains of the gene. 
The success of modified T7 DNA polymerase in 
the described multisite-directed mutagenesis proce- 
dures could be attributed to enzyme processivity, 
stability, and high rate of DNA polymerization 
(Tabor and Richardson, 1987a,b; Huber et al., 1987; 
Tabor et al., 1987). The expected probability of mul- 
tiple-site mutagenesis is the product of probabilities 
at each site. The more complicated the required 
changes (especially for the introduction of deletions 
or insertions), the lower the final probability of the 
multiple mutant. It appeared that T4 DNA poly- 
merase or PolIk in such experiments are not as 
efficient as modified T7 polymerase. 
(g) Recommended conditions and procedures for 
site- and multisite-directed mutagenesis 
Based on our results and using all the described 
solutions and buffers, we recommend the following 
protocol for 500 ng DNA reactions. 
(1) The mutagenic primer is annealed to U-contain- 
ing DNA templates in a molar ratio of 2-3 : 1. In a 
88 
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Fig. 4. Mutants verified by restriction enzyme analysis with PvuII (A and B) and by nucleotide sequencing (C). Mutagenesis was made 
as described in MATERIALS AND METHODS, section c. (Map A) PvuII restriction enzyme analysis of RF DNA from plaques with 
putative mutants (isolated on JMIOI). The restriction map ofwild-type MI3.pGH (W) DNA and the putative mutant M13.pGH.M (M) 
DNA. PvuH restriction sites on the map are indicated by downward arrows. In mutants, the 890-bp fragment is further restricted at 
the new PvuII site into two fragments, 568 bp and 247 bp. The 568-bp fragment indicating the 75-bp-long deletion helped in identifying 
the mutants. (Panel B) Polyacrylamide gel electrophoresis (3.5:;) of PvuII fragments after staining with ethidium bromide (see 
MATERIALS AND METHODS, section d). The fragments are from control DNA (wild type) prior to mutagenesis (C), non-mutated 
DNA after the mutagenesis (W), and mutant DNAs produced by mutagenesis (M); the letter is characterized by the presence of the 
small eppendorf tube add the following: 
7 ~1 DNA template (0.2 PM), 1~1 primer 
(0.5-0.6 PM), 2 ~1 5 x T7 DNA polymerase buf- 
fer (see MATERIALS AND METHODS, section c3i). 
Heat the tube at 65°C for 5 min, then allow to cool 
slowly to room temperature (40-60 min). Leave at 
room temperature for 15 min, then place the tube 
on ice for 15 min. 
(2) Extension/ligation reaction. To the above mix- 
ture add the following (on ice): 2 ~1 dNTP, 1.5 ~1 
ATP, 1 ~1 modified T7 DNA polymerase 
(14 units), and 1 ~1 T4 ligase (5 units). 
Incubate at 37 “C for 15 min, then immediately 
stop the reaction by heating at 65 ‘C for 5 min. 
(3) After the completion of the reaction, transfect 
JMlOl strain. As a control RZ1032 (ung- dut-) is 
used. Number of plaques on JMlOl (ung+ dut +) 
should be significantly lower than of those formed on 
RZ1032. The DNA can then be isolated and ana- 
lyzed for the mutation(s). 
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568-bp fragment. (Panel C) Autoradiogram of polyacrylamide gel (7.2%) showing nucleotide sequence of the region that has been 
reconstructed (M 13.pGH.M) and the wild type (M 13.pGH). Experimental details of nucleotide sequence are shown in MATERIALS 
AND METHODS, section e. The nt listed on both sides show the changes after the multisite-directed mutagenesis. (1) The G + A 
substitution (indicated by an asterisk) generating aPvuI1 restriction site. (2) A deletion in the presequence from nt + 4 to + 78 (inclusive) 
with respect to the start codon. (3) The ATG start codon, as a consequence of the deletion, is positioned just before the first codon 
(TTC, coding for phenylalanine) of the mature pGH gene. Number of nt, with respect to the start codon ATG, are shown superscript. 
The underlined sequence 5’-CAGCTG constitutes the newly generated PvuII site in the mutants. 
